EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSTTRG00000006074
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSTTRG00000007737
Gene Symbol: KDM1A
1 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSTTRG00000012255
Gene Symbol: LOXL2
1 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSTTRG00000002052
Gene Symbol: MIF
1 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSTTRG00000012417
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSTTRG00000002175
Gene Symbol: MMP13
1 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSTTRG00000001497
Gene Symbol: MMP14
1 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSTTRG00000001180
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSTTRG00000002168
Gene Symbol: MMP3
1 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSTTRG00000013489
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSTTRG00000012110
Gene Symbol: MMP9
1 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSTTRG00000001321
Gene Symbol: MTOR
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).